Skip to main content
LabGenomics. Co., Ltd. logo

LabGenomics. Co., Ltd. — Investor Relations & Filings

Ticker · 084650 ISIN · KR7084650001 KO Human health and social work activities
Filings indexed 372 across all filing types
Latest filing 2025-06-23 Board/Management Inform…
Country KR South Korea
Listing KO 084650

About LabGenomics. Co., Ltd.

http://www.labgenomics.co.kr/

LabGenomics is a biotechnology company specializing in molecular diagnostics and genetic analysis. The company's core activities are structured around three primary areas: diagnostic services, Next-Generation Sequencing (NGS), and the development and manufacturing of in-vitro diagnostic (IVD) products. It provides a comprehensive range of services, including general diagnostics, sample analysis, prenatal malformation testing, and cancer genetic testing. In addition to services, LabGenomics develops and sells diagnostic kits and devices, with a focus on applications for infectious diseases. The company is actively engaged in research and development to create innovative biotechnology products and is pursuing a global expansion strategy, notably through the acquisition of CLIA-certified laboratories to enhance its service capabilities.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of LabGenomics. It details the outgoing CEO, the incoming CEO, the reason for the change (resignation and new appointment), and the date of the board resolution. This falls directly under the category of board/management changes.
2025-06-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting' (제24기 임시주주총회 소집통지서) for LabGenomics. It contains the meeting agenda, voting procedures, electronic voting instructions, and detailed management information including board activities, director remuneration, and business overview. This document is a formal proxy statement and meeting notice sent to shareholders to solicit votes for the upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-05-29 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy/Reference Document for Exercise of Voting Rights). It provides detailed information to shareholders regarding an upcoming Extraordinary General Meeting (EGM), including the agenda items (appointment of a director and granting of stock options), the purpose of the solicitation, and instructions on how to vote. This document is a standard proxy solicitation material used to request shareholder votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-05-29 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for LabGenomics (랩지노믹스) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial and operational information, including company overview, management changes, capital structure, and business activities. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-05-15 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여). It details the terms, conditions, and recipients of the stock options. Since this is a specific regulatory disclosure regarding corporate capital/equity structure changes (stock options) that does not fit into the other specific categories like 'Director's Dealing' or 'Share Issue', it is classified as a Regulatory Filing (RNS).
2025-04-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Extraordinary General Meeting). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date for shareholder rights. This fits the definition of a general regulatory announcement regarding corporate actions.
2025-04-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.